Yang Li, Keyi Shi, Hengyi Qi, Wentian Cui, Qian Cai, Tizhen Yan, Baobiao Zhuo, Weiwei He
{"title":"Bibliometric and visualization analysis of cancer associated with intestinal flora through genetics and epigenetics from 1991 to 2024.","authors":"Yang Li, Keyi Shi, Hengyi Qi, Wentian Cui, Qian Cai, Tizhen Yan, Baobiao Zhuo, Weiwei He","doi":"10.21037/cco-25-13","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Intestinal flora, or gut microbiota, has increasingly been recognized for its potential role in cancer development and progression. Beyond direct interactions with systemic organs, gut microbiota and its metabolites can modulate epigenetic processes such as DNA methylation, histone modification, and non-coding RNA regulation. This study aims to bridge this gap by conducting a bibliometric and visualization analysis of the scientific literature on cancer associated with intestinal flora.</p><p><strong>Methods: </strong>We utilized bibliometric software to examine publication trends, citation patterns, and collaborative networks within the field. Visualization techniques were applied to pinpoint influential authors, institutions, and countries. The analysis encompassed a comprehensive search of relevant databases to gather data on publications related to intestinal flora and cancer.</p><p><strong>Results: </strong>Our findings indicate a substantial rise in publications over recent decades, signifying an intensifying focus on the intestinal flora-cancer connection. Key research hotspots identified include the microbiota's role in colorectal cancer, the interplay between microbiota and the host immune system, the epigenetic impacts of gut microbiota on cancer development, and the promise of microbiota-targeted therapies for cancer treatment. The analysis also revealed a network of prominent researchers, leading institutions, and countries at the forefront of this research area.</p><p><strong>Conclusions: </strong>This study offers a panoramic view of the current research on cancer associated with intestinal flora and underscores potential avenues for future exploration. The insights gleaned from our bibliometric and visualization analysis may guide the development of targeted strategies for cancer prevention and treatment, harnessing the power of the gut microbiota.</p>","PeriodicalId":9945,"journal":{"name":"Chinese clinical oncology","volume":"14 4","pages":"39"},"PeriodicalIF":2.5000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chinese clinical oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21037/cco-25-13","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Intestinal flora, or gut microbiota, has increasingly been recognized for its potential role in cancer development and progression. Beyond direct interactions with systemic organs, gut microbiota and its metabolites can modulate epigenetic processes such as DNA methylation, histone modification, and non-coding RNA regulation. This study aims to bridge this gap by conducting a bibliometric and visualization analysis of the scientific literature on cancer associated with intestinal flora.
Methods: We utilized bibliometric software to examine publication trends, citation patterns, and collaborative networks within the field. Visualization techniques were applied to pinpoint influential authors, institutions, and countries. The analysis encompassed a comprehensive search of relevant databases to gather data on publications related to intestinal flora and cancer.
Results: Our findings indicate a substantial rise in publications over recent decades, signifying an intensifying focus on the intestinal flora-cancer connection. Key research hotspots identified include the microbiota's role in colorectal cancer, the interplay between microbiota and the host immune system, the epigenetic impacts of gut microbiota on cancer development, and the promise of microbiota-targeted therapies for cancer treatment. The analysis also revealed a network of prominent researchers, leading institutions, and countries at the forefront of this research area.
Conclusions: This study offers a panoramic view of the current research on cancer associated with intestinal flora and underscores potential avenues for future exploration. The insights gleaned from our bibliometric and visualization analysis may guide the development of targeted strategies for cancer prevention and treatment, harnessing the power of the gut microbiota.
期刊介绍:
The Chinese Clinical Oncology (Print ISSN 2304-3865; Online ISSN 2304-3873; Chin Clin Oncol; CCO) publishes articles that describe new findings in the field of oncology, and provides current and practical information on diagnosis, prevention and clinical investigations of cancer. Specific areas of interest include, but are not limited to: multimodality therapy, biomarkers, imaging, tumor biology, pathology, chemoprevention, and technical advances related to cancer. The aim of the Journal is to provide a forum for the dissemination of original research articles as well as review articles in all areas related to cancer. It is an international, peer-reviewed journal with a focus on cutting-edge findings in this rapidly changing field. To that end, Chin Clin Oncol is dedicated to translating the latest research developments into best multimodality practice. The journal features a distinguished editorial board, which brings together a team of highly experienced specialists in cancer treatment and research. The diverse experience of the board members allows our editorial panel to lend their expertise to a broad spectrum of cancer subjects.